Polymorphism of Fcγ RIIa may affect the efficacy of γ-globulin therapy in Kawasaki disease

Journal of Clinical Immunology

Volumn 25, Issue 4, 2005, Pages 309-313

  Taniuchi, Shoichiro ^a   Masuda, Midori ^a   Teraguchi, Masayuki ^a   Ikemoto, Yumiko ^a   Komiyama, Yutaka ^a   Takahashi, Hakuo ^a   Kino, Minoru ^b   Kobayashi, Yohnosuke ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Nakano Children's Hospital   (Japan)

Author keywords

Aneurysm; Fc RIIa; Fc RIIIa; Fc RIIIb; Kawasaki disease; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; FC RECEPTOR; GENOMIC DNA; IMMUNOGLOBULIN;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA EXTRACTION; DRUG EFFICACY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL;

ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; FEMALE; GAMMA-GLOBULINS; GENOTYPE; HUMANS; IMMUNIZATION, PASSIVE; INFANT; INJECTIONS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RETROSPECTIVE STUDIES;

EID: 23944446340     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10875-005-4697-7     Document Type: Article

References (20)

1. Council on Cardiovascular Disease in the Young Committee on Rheumatic Fever: Endocarditis and Kawasaki Disease American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 103:335, 2001
2. Furusho K, Kamiya T, Nakano H, et al.: High-dose intravenous γ-globulin for Kawasaki disease. Lancet 2:1055-1058, 1984
3. Newburger JW, Takahashi M, Beiser AS, et al.: A single intravenous infusion of γ-globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639, 1991
4. Tsujimoto H, Takeshita S, Nakatani K, et al.: Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol 103:161-168, 2002
5. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S: Predictors of coronary artery lesions after intravenousγ-globulin treatment in Kawasaki disease. J Pediatr 137:177-180, 2000
6. de Haas M: IgG-Fc receptors and the clinical relevance of their polymorphism. Wien Klin Wochenschr 113:825-831, 2001
7. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE: Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: A study of 21 individuals from 14 families. Blood 86:2403-2413, 1995
8. Jiang XM, Arepally G, Poncz M, McKenzie SE: Rapid detection of the Fcγ RIIa-H/R131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods 199:55-59, 1996
9. Nieto AR, Caliz M, Pascula L, et al.: Involvement of Feγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 43:735-739, 2000
10. Harada K: Intravenous -γ globulin treatment in Kawasaki disease. Acta Paediaritr Jpn 33:805-810, 1991
11. Koene HR, Kleijer M, Algra J, et al.: Fcγ RIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fcγ RIIIa, independently of the Fcγ RIIIa-48L/R/H phenotype. Blood 90:1109-1114, 1997
12. Huizinga TW, Kleijer M, Tetteroo PA, Roos D, von dem Borne AE: Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fcγ receptor III (CD16). Blood 75:213-217, 1990
13. Koene HR, Kleijer M, Swaak AJ, et al.: The Fcγ RIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum 41:1813-1818, 1998
14. Wu J, Metz C, Xu X, et al.: A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: A candidate background gene in African American systemic lupus erythematosus. J Immunol 170:132-138, 2003
15. Philip S, Lee WC, Liu SK, Wu MH, Lue HC: A swine model of horse serum-induced coronary vasculitis: An implication for Kawasaki disease. Pediatr Res. 55:211-219, 2004
16. Takeshita S, Sekine I, Fujisawa T, Yoshioka S: Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease - The pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-CSF). Acta Paediatr Jpn 32:508-514, 1990
17. Naoe S, Takahashi K, Masuda H, Tanaka N: Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 41:785-797, 1991
18. Sanders LA, Feldman RG, Voorhorst-Ogink MM, et al.: Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 63(1):73-81, 1995 (Jan).
19. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW: A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81:1116-1120, 1998
20. Takagi N, Kihara M, Yamaguchi S, et al.: Plasma exchange in Kawasaki disease. Lancet 346:1307, 1995